Skip to main content
. 2016 Apr 18;36:450–461. doi: 10.1007/s10875-016-0279-0

Table 2.

Mean health resource utilization per patient before and 12 months after IgG treatment initiation

Health Resource Utilization Adult Patients (Age ≥18 Years) Pediatric Patients (Age <18 Years)
n Baseline (12-Months Pre-treatment),a
Mean (SD)
12- Months, Mean (SD) p-value n Baseline (12-Months Pre-treatment),a
Mean (SD)
12 Months, Mean (SD) p-value
Regularly scheduled office visits 16 7.1 (7.8) 8.9 (8.7) NS 7 10.6 (5.3) 11.3 (5.7) NS
Unscheduled office visits 17 11.6 (15.6) 3.8 (5.4) NS 7 20.0 (9.2) 8.3 (6.8) 0.01
Emergency room visits 17 1.8 (2.4) 0.4 (0.7) <0.05 7 6.3 (8.3) 1.9 (3.3) NS
Hospital admissions 17 1.4 (2.4) 0.2 (0.4) 0.05 8 2.8 (2.1) 0.4 (0.5) 0.01
Length of stayb -- -- -- 3 46.0 (46.1) 7.7 (8.1) NS
Number of serious infectionsc 12 8.0 (7.2) 2.5 (1.6) <0.05 6 16.7 (9.0) 5.0 (2.1) <0.05
Days missed from work or schoold 12 25.5 (36.9) 37.4 (103.4) NS 4 63.5 (77.8) 46.0 (36.5) NS
Number of antibiotic prescriptions 16 5.5 (4.0) 2.5 (2.3) <0.01 6 11.3 (9.0) 4.2 (2.6) NS

aPre-enrollment data was annualized

bOnly 1 adult patient had length-of-stay data

cSerious infections defined as: acute or chronic sinusitis, bronchitis, pneumonia, ear infection, or other acute or chronic infection

dFour adult patients who were retired were excluded from this analysis

ER emergency room, IgG immunoglobulin G, NS not significant, SD standard deviation